Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Blood|January 5, 2017
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamideChristopher G Kanakry, Javier Bolaños-Meade, Yvette L Kasamon, et al.Haematologica|November 16, 2016
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R McCurdy, Yvette L Kasamon, Christopher G Kanakry, et al.Haematologica|May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapyJonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older AdultsYvette L Kasamon, Javier Bolaños-Meade, Gabrielle T Prince, et al.Blood|March 28, 2015
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R McCurdy, Jennifer A Kanakry, Margaret M Showel, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Central Nervous System Cancers, Version 1.2015Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.Pageof 8